# Labeling for Biosimilar Products Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/labeling-for-biosimilar-products-guidance-for-industry/e13343b3-e9e8-436e-9bcc-ec73cae4d41c

> FDA guidance document: Labeling for Biosimilar Products Guidance for Industry. Issue date: July 18, 2018. Get complete insights and analysis.

---

## Details

- Title: Labeling for Biosimilar Products Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2018-07-18
- Comment Close Date: 2018-10-18
- Last Changed: 2020-04-24
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2016-D-0643">FDA-2016-D-0643</a>

## Related Documents

- [Referencing Approved Drug Products in ANDA Submissions Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/referencing-approved-drug-products-in-anda-submissions-guidance-for-industry/a3f26b8f-0c5a-443b-b665-6fef99ae7de4)
- [Homeopathic Drug Products Guidance for FDA Staff and Industry](https://www.globalkeysolutions.net/guidances/guidance-document/homeopathic-drug-products-guidance-for-fda-staff-and-industry/f8c7cdc9-599a-4ab0-9f93-eeb2b899427c)
- [Elemental Impurities in Drug Products Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/elemental-impurities-in-drug-products-guidance-for-industry/5931c496-e20b-426d-915b-0856db49e99e)